SAFE AND EFFECTIVE TARGETING OF BREAST CANCER PROGENITOR CELLS WITH A NOTCH 3 ANTIBODY-DRUG CONJUGATE

$1,064,427FY2014Department of DefenseDOD

University Of California, Los Angeles

Investigators